Helen M Bronte-Stewart
Neuropsychiatry · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Helen M Bronte-Stewart’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G63510 · Current
Licensed to practise in California · since 1988 · expires 2028-07-31 · University of Pennsylvania School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$13,345
Medicare paid this office $13,345 for 74 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 31 | $3,987 | $97 |
| Physician review of gait analysis test | 22 | $1,968 | $89 |
| Test or measurement for functional capacity, each 15 minutes | 14 | $735 | $29 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 11 | $464 | $36 |
Who their Medicare patients are
74 Original Medicare patients in 2024. Average age 75 · Women 42% · Health risk score 1.21. At or below the middle of the specialty; the typical neuropsychiatry clinician is at 1.55.
Conditions among them: High blood pressure 54% · Depression 24% · Coronary heart disease 22% · Diabetes 18% · Cancer 18% · Dementia 18%.
The office billed $75,422, Medicare allowed $19,726 and paid $13,345; for 172 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 74 | 172 | 75 | 1.21 | $75,422 | $13,345 |
| 2023 | 74 | 225 | 74 | 1.32 | $96,419 | $20,344 |
| 2022 | 89 | 298 | 74 | 1.10 | $135,106 | $26,582 |
| 2021 | 132 | 445 | 73 | 1.23 | $208,682 | $34,868 |
| 2020 | 188 | 522 | 73 | 1.18 | $260,093 | $32,674 |
| 2019 | 175 | 620 | 73 | 1.39 | $266,035 | $39,243 |
| 2018 | 131 | 411 | 72 | 1.19 | $223,318 | $35,962 |
| 2017 | 121 | 309 | 73 | 1.32 | $169,449 | $27,060 |
| 2016 | 123 | 333 | 72 | 1.20 | $159,728 | $29,418 |
| 2015 | 111 | 383 | 71 | 1.18 | $175,247 | $37,381 |
| 2014 | 167 | 428 | 71 | 1.27 | $160,432 | $34,941 |
| 2013 | 227 | 578 | 72 | 1.26 | $202,518 | $40,393 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Long return visit (40+ min) | 40 | $9,410 | $122 |
| Physician review of gait analysis test | 17 | $1,789 | $99 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 18 | $1,184 | $41 |
2022: 8 services
| Long return visit (40+ min) | 46 | $9,109 | $112 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, each additional hour | 14 | $4,034 | $161 |
| Return visit (30+ min) | 22 | $2,169 | $83 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, first hour | 14 | $2,092 | $149 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 21 | $1,249 | $40 |
| Physician review of gait analysis test | 11 | $1,122 | $102 |
| Measurement of range of motion in arm, leg or each spine section | 13 | $109 | $7 |
| Measurement of range of motion of hand | 12 | $60 | $5 |
2021: 9 services
| Long return visit (40+ min) | 44 | $10,361 | $120 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, each additional hour | 19 | $5,580 | $164 |
| Return visit (30+ min) | 23 | $3,355 | $82 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, first hour | 19 | $2,885 | $152 |
| Test for balance and posture | 57 | $2,564 | $31 |
| Injection of chemical for paralysis of salivary glands on both sides of mouth | 11 | $2,461 | $72 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 31 | $2,011 | $40 |
| Measurement of range of motion in arm, leg or each spine section | 18 | $168 | $7 |
| Measurement of range of motion of hand | 18 | $91 | $5 |
2020: 10 services
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, each additional hour | 21 | $6,777 | $165 |
| Test for balance and posture | 117 | $4,070 | $29 |
| Return visit (30+ min) | 33 | $3,422 | $67 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, first hour | 21 | $3,212 | $153 |
| Long return visit (40+ min) | 24 | $2,791 | $90 |
| Injection of chemical for paralysis of salivary glands on both sides of mouth | 11 | $2,063 | $69 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 26 | $1,952 | $43 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | 20 | $1,534 | $38 |
| Measurement of range of motion in arm, leg or each spine section | 21 | $242 | $8 |
| Measurement of range of motion of hand | 21 | $118 | $6 |
2019: 11 services
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, each additional hour | 32 | $10,474 | $161 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, first hour | 32 | $4,787 | $150 |
| Long return visit (40+ min) | 25 | $3,785 | $97 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | 35 | $3,441 | $38 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 36 | $2,728 | $42 |
| Test for balance and posture | 95 | $2,622 | $24 |
| Return visit (30+ min) | 31 | $2,441 | $64 |
| Short return visit (20+ min) | 19 | $975 | $44 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | 17 | $306 | $16 |
| Measurement of range of motion in arm, leg or each spine section | 27 | $193 | $7 |
| Measurement of range of motion of hand | 32 | $175 | $5 |
2018: 11 services
| Electronic analysis and programming of implanted complex deep brain neurostimulator generator system, first hour | 32 | $7,503 | $150 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, each additional hour | 18 | $5,859 | $158 |
| Electronic analysis and programming of implanted complex deep brain neurostimulator generator system, first hour | 21 | $3,654 | $174 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, first hour | 18 | $2,634 | $146 |
| Long return visit (40+ min) | 15 | $1,515 | $80 |
| Return visit (30+ min) | 16 | $1,435 | $65 |
| Test for balance and posture | 52 | $1,387 | $23 |
| Long return visit (40+ min) | 11 | $1,197 | $100 |
| Short return visit (20+ min) | 16 | $876 | $46 |
| Measurement of range of motion in arm, leg or each spine section | 16 | $111 | $7 |
| Measurement of range of motion of hand | 18 | $97 | $5 |
2017: 5 services
| Electronic analysis and programming of implanted complex deep brain neurostimulator generator system, first hour | 38 | $10,735 | $158 |
| Long return visit (40+ min) | 14 | $1,744 | $83 |
| Test for balance and posture | 64 | $1,694 | $21 |
| Return visit (30+ min) | 17 | $1,622 | $71 |
| Short return visit (20+ min) | 13 | $593 | $46 |
2016: 9 services
| Electronic analysis and programming of implanted complex deep brain neurostimulator generator system, first hour | 40 | $12,197 | $158 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, each additional hour | 17 | $3,884 | $149 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, first hour | 18 | $2,524 | $140 |
| Return visit (30+ min) | 30 | $2,332 | $61 |
| Test for balance and posture | 53 | $1,524 | $24 |
| Long return visit (40+ min) | 11 | $1,433 | $110 |
| Short return visit (20+ min) | 20 | $980 | $45 |
| Measurement of range of motion in arm, leg or each spine section | 14 | $96 | $7 |
| Measurement of range of motion of hand | 16 | $86 | $5 |
2015: 9 services
| Electronic analysis and programming of implanted complex deep brain neurostimulator generator system, first hour | 46 | $13,509 | $165 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, each additional hour | 29 | $8,520 | $155 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, first hour | 29 | $4,301 | $143 |
| Electronic analysis and programming of implanted complex deep brain neurostimulator generator system | 14 | $3,302 | $81 |
| New patient visit (60+ min) | 12 | $1,428 | $119 |
| Test for balance and posture | 38 | $1,089 | $24 |
| Short return visit (20+ min) | 17 | $865 | $46 |
| Measurement of range of motion in arm, leg or each spine section | 22 | $152 | $7 |
| Measurement of range of motion of hand | 25 | $140 | $5 |
2014: 9 services
| Electronic analysis and programming of implanted complex deep brain neurostimulator generator system, first hour | 61 | $13,635 | $157 |
| Return visit (30+ min) | 58 | $4,545 | $63 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, each additional hour | 17 | $3,542 | $154 |
| Short return visit (20+ min) | 51 | $3,184 | $45 |
| Measurement of brain wave activity (eeg) with electrodes on brain to provoke seizures or identify brain structures, first hour | 17 | $2,422 | $142 |
| Test for balance and posture | 61 | $1,654 | $23 |
| Long return visit (40+ min) | 16 | $1,464 | $92 |
| Measurement of range of motion in arm, leg or each spine section | 12 | $83 | $7 |
| Measurement of range of motion of hand | 13 | $70 | $5 |
2013: 5 services
| Electronic analysis and programming of implanted complex deep brain neurostimulator generator system, first hour | 64 | $15,950 | $152 |
| Return visit (30+ min) | 47 | $4,616 | $66 |
| Test for balance and posture | 147 | $4,251 | $23 |
| Short return visit (20+ min) | 53 | $3,389 | $44 |
| Long return visit (40+ min) | 17 | $1,493 | $83 |
Drugs they prescribed that Part D paid
$19,053
Pharmacies billed $19,053 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 147) in 2024. At or below the middle of the specialty; the typical neuropsychiatry clinician is at 0%.
133 generic and 14 brand-name prescriptions · $19,053 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Carbidopa-Levodopa Er | 11 | $1,685 | $43 |
| Carbidopa-Levodopa | 15 | $1,344 | $26 |
Year by year
| 2024 | 147 | 24 | 0% (0) | 10% | $19,053 |
| 2023 | 212 | 31 | 0% (0) | None | $34,181 |
| 2022 | 139 | 25 | 0% (0) | 17% | $26,399 |
| 2021 | 127 | 26 | 0% (0) | None | $11,854 |
| 2020 | 191 | 29 | 0% (0) | 10% | $26,798 |
| 2019 | 260 | 30 | 0% (0) | 8% | $27,666 |
| 2018 | 273 | 36 | 0% (0) | 6% | $32,640 |
| 2017 | 207 | 34 | 0% (0) | None | $20,293 |
| 2016 | 294 | 32 | 0% (0) | 5% | $23,210 |
| 2015 | 330 | 38 | 0% (0) | 5% | $20,858 |
| 2014 | 366 | 43 | 0% (0) | 7% | $28,707 |
| 2013 | 342 | 34 | 0% (0) | 10% | $33,135 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Myrbetriq | 16 | $8,579 | $536 |
| Carbidopa-Levodopa | 70 | $3,147 | $45 |
| Carbidopa-Levodopa Er | 52 | $2,571 | $49 |
| Midodrine | 12 | $783 | $65 |
2022: 4 drugs
| Myrbetriq | 11 | $7,692 | $699 |
| Carbidopa-Levodopa-Entacapone | 13 | $4,804 | $370 |
| Carbidopa-Levodopa | 42 | $3,351 | $80 |
| Carbidopa-Levodopa Er | 29 | $1,954 | $67 |
2021: 3 drugs
| Carbidopa-Levodopa | 43 | $4,643 | $108 |
| Carbidopa-Levodopa Er | 27 | $2,225 | $82 |
| Clonazepam | 13 | $70 | $5 |
2020: 4 drugs
| Carbidopa-Levodopa | 62 | $4,749 | $77 |
| Carbidopa-Levodopa Er | 53 | $3,802 | $72 |
| Trazodone | 12 | $99 | $8 |
| Clonazepam | 11 | $67 | $6 |
2019: 8 drugs
| Carbidopa-Levodopa | 67 | $6,509 | $97 |
| Myrbetriq | 14 | $5,436 | $388 |
| Carbidopa-Levodopa Er | 62 | $3,979 | $64 |
| Amantadine | 12 | $1,426 | $119 |
| Memantine | 12 | $545 | $45 |
| Gabapentin | 17 | $211 | $12 |
| Clonazepam | 23 | $130 | $6 |
| Trazodone | 11 | $120 | $11 |
2018: 6 drugs
| Carbidopa-Levodopa | 74 | $6,534 | $88 |
| Carbidopa-Levodopa Er | 51 | $4,163 | $82 |
| Amantadine | 18 | $2,901 | $161 |
| Rivastigmine | 15 | $2,314 | $154 |
| Clonazepam | 28 | $264 | $9 |
| Propranolol | 11 | $158 | $14 |
2017: 4 drugs
| Carbidopa-Levodopa | 60 | $4,939 | $82 |
| Amantadine | 30 | $3,308 | $110 |
| Carbidopa-Levodopa Er | 58 | $2,965 | $51 |
| Clonazepam | 16 | $171 | $11 |
2016: 5 drugs
| Azilect | 11 | $10,982 | $998 |
| Carbidopa-Levodopa | 115 | $4,756 | $41 |
| Carbidopa-Levodopa Er | 78 | $2,345 | $30 |
| Amantadine | 30 | $1,881 | $63 |
| Clonazepam | 24 | $297 | $12 |
2015: 5 drugs
| Carbidopa-Levodopa | 130 | $6,476 | $50 |
| Carbidopa-Levodopa-Entacapone | 12 | $4,123 | $344 |
| Carbidopa-Levodopa Er | 78 | $2,967 | $38 |
| Amantadine | 25 | $1,004 | $40 |
| Clonazepam | 41 | $305 | $7 |
2014: 9 drugs
| Carbidopa-Levodopa | 156 | $7,861 | $50 |
| Carbidopa-Levodopa-Entacapone | 11 | $4,970 | $452 |
| Carbidopa-Levodopa Er | 83 | $3,067 | $37 |
| Rivastigmine | 12 | $2,019 | $168 |
| Amantadine | 17 | $1,536 | $90 |
| Ropinirole | 13 | $364 | $28 |
| Clonazepam | 33 | $323 | $10 |
| Bupropion Xl | 11 | $291 | $26 |
| Propranolol | 11 | $52 | $5 |
2013: 7 drugs
| Carbidopa-Levodopa-Entacapone | 18 | $8,426 | $468 |
| Carbidopa-Levodopa | 134 | $6,700 | $50 |
| Carbidopa-Levodopa Er | 89 | $3,604 | $40 |
| Amantadine | 12 | $1,206 | $100 |
| Pramipexole Dihydrochloride | 13 | $594 | $46 |
| Clonazepam | 37 | $308 | $8 |
| Ropinirole | 11 | $308 | $28 |
Money from drug and device companies
$46 in 2025
| 2025 | 1 | 2 | None | $46 |
| 2024 | 1 | 1 | $1,420 | $1,420 |
| 2023 | 1 | 1 | None | $139 |
| 2022 | 2 | 2 | None | $83 |
| 2021 | 1 | 1 | None | $47 |
| 2020 | 2 | 2 | $3,920 | $4,045 |
| 2019 | 1 | 4 | $445 | $816 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Percept PC Brainsense | $46 | 2 payments
|
See all 2 published payments
| Medtronic | Meals · 2025-03-25 | Percept PC Brainsense | $22 |
| Medtronic | Meals · 2025-03-19 | Percept PC Brainsense | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,420
| Genentech USA | None | $1,420 | 1 payment
|
2023: $139
| Medtronic | Percept PC Brainsense | $139 | 1 payment
|
2022: $83
| Supernus Pharmaceuticals | None | $63 | 1 payment
|
| Cala Health | Cala Trio | $20 | 1 payment
|
2021: $47
| Medtronic | Percept | $47 | 1 payment
|
2020: $4,045
| Medtronic USA | Percept | $3,920 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $125 | 1 payment
|
2019: $816
| Medtronic USA | Activa | $816 | 4 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Boston Scientific Corporation · Nrac Dbs Collaborations · 2025 | Their institution | $98,330 |
| Medtronic, Inc. · Adapt-Pd Trial · 2023 | Their institution | $93,511 |
| Boston Scientific Corporation · Neurostimulation of the Nucleus Basalis of Meynert for the Cognitive Motor Syndrome in Parkinsons Disease Cranmb0011 · 2023 | Their institution | $87,036 |
| Medtronic, Inc. · Adapt-Pd Trial · 2022 | Their institution | $87,000 |
| Medtronic, Inc. · Adapt-Pd Trial · 2021 | Their institution | $76,933 |
| Medtronic, Inc. · Investigator Sponsored Research · 2021 | Their institution | $42,908 |
| Medtronic, Inc. · Adapt-Pd Trial · 2024 | Their institution | $38,482 |
| Boston Scientific Corporation · Neurostimulation of the Nucleus Basalis of Meynert for the Cognitive-Motor Syndrome in Parkinson'S Disease · 2024 | Their institution | $32,180 |
| Medtronic USA, Inc. · Investigator Sponsored Research · 2019 | Their institution | $31,340 |
| Medtronic, Inc. · Adapt-Pd Trial · 2025 | Their institution | $25,700 |
| Medtronic USA, Inc. · Investigator Sponsored Research · 2020 | Their institution | $24,206 |
| Medtronic, Inc. · Investigator Sponsored Research · 2022 | Their institution | $14,408 |
| Medtronic USA, Inc. · Lfp Beta Adbs Feasibility · 2019 | Their institution | $13,193 |
| Medtronic USA, Inc. · Adapt-Pd Trial · 2020 | This clinician | $2,540 |
| Medtronic USA, Inc. · Adapt-Pd Trial · 2019 | This clinician | $1,397 |
| Medtronic USA, Inc. · 2019 | This clinician | $1,016 |
| Medtronic, Inc. · Adapt-Pd Trial · 2021 | This clinician | $508 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1295786804
- Licence
- CA G63510California G63510: Current · expires 2028-07-31
- Trained
- Perelman School of Med at the University of Pennsylvania, 1984
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 1295786804
- Taxonomy
- Federal specialty code 2084N0600X (2084N0600X); Neurology (2084N0400X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-05-16
- NPI last updated
- 2023-11-09
- NPI record certified
- 2023-11-09
This is when the NPI record was last certified, not a medical board exam.